ERNA

$2.02+3.59%

Ernexa Therapeutics Inc.

Market Cap

$3M

Live price × SEC shares (Aug 6, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

2.69

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

1.0

Mkt cap / shareholders' equity

Flagged input, hover for details

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Cost of revenue				0.00
Research & development	1,035	676	1,915	2,792	6,418
Total operating expenses	1,993	2,094	5,590	4,104	13,781
Operating income	(1,993)	(2,094)	(5,590)	(4,104)	(13,781)
Interest expense	0.00	0.00
Pretax income	(1,234)	(1,564)	(5,546)	(4,009)	(12,353)
Income tax	6.0	(62.0)	(40.0)	0.0	(96.0)
Net income	(1,240)	(1,502)	(5,506)	(4,009)	(12,257)
EPS (basic) ($)	(0.15)		(6.95)	(3.40)	—
EPS (diluted) ($)	(0.15)		(6.95)	(3.40)	—
Weighted avg. shares (basic)	8,226		792	1,183
Weighted avg. shares (diluted)	8,226		792	1,183

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

11 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Oct 15, 2026 accepted 5:25 PM ET	7.01Reg FD disclosure	Document SEC ↗
Sep 16, 2026 accepted 5:30 PM ET	7.01Reg FD disclosure	Document SEC ↗
Sep 16, 2026 accepted 4:50 PM ET	5.02Officer / director change	Document SEC ↗
Jul 2, 2026 accepted 4:40 PM ET	7.01Reg FD disclosure	Document SEC ↗
Jul 2, 2026 accepted 4:30 PM ET	5.07Shareholder vote	Document SEC ↗
Jun 26, 2026 accepted 4:30 PM ET	5.02Officer / director change	Document SEC ↗
May 4, 2026 accepted 4:10 PM ET	5.03Bylaws / fiscal year	Document SEC ↗
Mar 20, 2026 accepted 5:00 PM ET	3.01Delisting notice	Document SEC ↗
Feb 26, 2026 accepted 4:31 PM ET	7.01Reg FD disclosure	Document SEC ↗
Feb 11, 2026 accepted 5:10 PM ET	1.01Material agreement8.01Other events	Document SEC ↗